<DOC>
	<DOCNO>NCT03093246</DOCNO>
	<brief_summary>The aim randomize controlled clinical trial superiority evaluate effect 900 mg omega-3 polyunsaturated fatty acid 100 mg aspirin daily supplementation period 180 day adjunct non-surgical therapY patient generalize aggressive periodontitis . Probing depth , clinical attachment level , gingival index concentration microorganism cytokine baseline , 3 , 6 12 month procedure evaluate .</brief_summary>
	<brief_title>Omega-3 Plus Low-dose Aspirin Daily Supplementation Non-surgical Therapy Treat Aggressive Periodontitis</brief_title>
	<detailed_description>The study methodology accord CONSORT-STATEMENT 2010 randomize control clinical trial . Study Design The study design prospective , interventional , parallel , blind , randomize , control clinical trial superiority . Source data The population study recruit among patient refer Science Technology Institute - ICT- São José do Campos , College Dentistry . Patients fill healthy history questionnaire ensure medically qualified participate study . Based power calculation study , population 38 patient include . Considering α 5 % 10 % β-type error ( 90 % power ) detect difference least 1 mm probe depth reduction pocket ≥ 5 mm group , standard deviation 0.94 previous study evaluate different antimicrobial treatment GAgP ( Xajigeorgiou et al. , 2006 ) , 19 patient need group . Clinical Parameters All clinical parameter assess single blind , train calibrated examiner ( CFA ) periodontal therapy ( baseline ) 3 6 month use manual probe . Measurements do six site per tooth ( mesiobuccal , buccal , disto-buccal , distolingual , lingual , mesiolingual ) teeth , except third molar . The following clinical parameter evaluate : 1 ) Full-mouth plaque index ( FMPI ) ; 2 ) Bleeding probe ( BoP ) ; 3 ) Probing depth ( PD ) : distance bottom sulcus/pocket gingival margin ; 4 ) Gingival recession ( GM ) : distance free gingival margin cement-enamel junction ( CEJ ) ; 5 ) Clinical attachment level ( CAL ) : distance bottom sulcus/pocket CEJ . The CEJ identify careful probe cervical area . Calibration Randomization Initially , total ten patient present GAgP select . The designated examiner ( CFA ) measure CAL PD patient twice within 24 hour , interval ≥ 1 hour examination . Then , measure submit intraclass correlation test examiner judge calibrate reach 90 % agreement . Patients allocate two group accord computer-generated list . The allocation implement investigator ( NC ) directly involve examination treatment procedure . Treatment Protocols All patient treat periodontal therapy one-stage , full mouth , ultrasonic debridement ( FMUD ) . In single session , patient receive local anesthesia periodontal debridement ultrasound equipment ( Cavitron - Dentsply EUA ) subgingival tip ( UI25KSF10S , Hu-Friedy ) . All diseased site instrument one session . The debridement session perform single experienced train periodontist ( NA ) , different examiner . Immediately mechanical therapy , patient allocate one two treatment protocol : Test group ( n = 19 ) : FMUD + 900 mg omega-3 polyunsaturated fatty acid 100 mg aspirin daily supplementation period 180 day ; Control group ( n = 19 ) : FMUD + placebo pill . All patient start take pill immediately FMUD session . Microbiological evaluation Subgingival microbiological sample collect baseline , 3 6 month therapy . The site isolate sterile cotton roller supragingival biofilm carefully remove periodontal curette sterile paper insert periodontal pocket 30 ( Hartoth et al. , 1999 ) . The sample store sterile microtubes . The sample lyophilize sent Department Periodontology University Florida , sample analyze . Evaluation cytokine For analysis immunological change , crevicular gingival fluid ( CGF ) collect baseline , 3 6 month treatment . Each site isolate sterile cotton roller supragingival biofilm remove . After , CGF collect Periopaper strip ( Periopaper , Oraflow , Plainview , NY , USA ) , insert pocket 15 second . The volume collect fluid measure ( Periotron 8000 , Oraflow ) . The Periopaper strip store sterile tube contain 300μl phosphate saline ( PBS ) 5 % Tween-20 store freezer -20 ° C multiplex test . The level follow cytokine measure CGF : interferon ( IFN ) -γ , interleukin ( IL ) -10 , -1β , -4 , -6 , -8 , tumor necrosis factor ( TNF ) -α , macrophage inflammatory protein 1α ( MIP1α ) , 1α monocyte chemotactic protein ( MCP-1α ) . The 10-plex high sensitivity kit ( Millipore Corporation , Billerica , MA , USA ) use accord manufacturer 's instruction analyze use MAGpixTM platform ( MiraiBio , Alameda , CA , USA ) . Samples analyze individually ( pocket separately ) concentration calculate use standard 5-parameter curve Xponet program ( Millipore Corporation ) . The concentration marker give pg / ml . All analysis cytokine concentration do duplicate . Statistical analysis Two analyzes perform : Per Protocol Intention-to-treat ( Moher , 2010 ; Gupta , 2011 ; Day , 2008 ) . For , mean standard deviation calculate parameter . Full-mouth PI , GI , PD , CAL , GR submit Shapiro-Wilk test evaluate distribution data , subject variance test intra- intra-group comparison . In addition , number pocket ≥ 5mm , frequency closure pocket , mean reduction PS gain CAL pocket assess therapy perform intra- inter-group analyzes . The concentration cytokine analyze test variance intra intergroup comparison .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Aggressive Periodontitis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>diagnosis GAgP ( AAP , 1999 ) ; presence ≥20 teeth ; presence ≥ 6 site present PD ≥ 5mm bleed probing ( BOP ) ≥2 site PD ≥7mm ( include incisor first molar , addition two noncontiguous teeth ) ; good general health ; agree participate study sign write informed consent . All subject individually inform objective , probable risk benefit protocol treatment ( accord Resolution nº196 October 1996 Professional Code Dental Ethics 179/93 ) . pregnancy lactate ; suffer systemic disease ( e.g . cardiovascular disorder , diabetes , blood dyscrasia , immunodeficiency , etc ) could alter course periodontal disease ; take antimicrobial previous 6 month ; take longterm antiinflammatory drug ; previous periodontal treatment within last 12 month ; smoker ≥ 10 cigarette .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Full-mouth ultrasonic debridement</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Omega-3 polyunsaturated fatty acid</keyword>
	<keyword>Non-surgical therapy</keyword>
</DOC>